• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Ascites

Ascites - 120 Studies Found

Terminated : Trial of Sunitinib for Refractory Malignant Ascites
: Ascites
: 2008-11-21
: Drug: Sunitinib Patients will be given Sunitinib 50 mg orally daily for four weeks, followed by a two we
Completed : Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance
: Ascites
: 2009-12-10
: Device: NovaShunt's Automated Fluid Shunt implantation The Automated Fluid Shunt (AFS) Device consists o
Terminated : Sodium Restriction in the Management of Cirrhotic Ascites
: Ascites
: 2007-10-22
:
  • Other: Sodium restriction 4 gr

Completed : To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites
: Ascites
: 2015-12-05
:
  • Drug: Propranolol Propranolol

Terminated : An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites
: Malignant Ascites
: 2010-02-25
:
  • Procedure: paracentesis surgic

Recruiting : Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology
: Refractory Malignant Ascites
: 2015-06-16
:
  • Procedure: Paracentesis
  • Device: Tunneled I

Withdrawn : A Study of Bevacizumab to Prevent Malignant Ascites
: Malignant Ascites
: 2009-05-21
: Drug: Bevacizumab Bevacizumab is given as an IV infusion of 15 mg/kg every three weeks for 12 weeks.
Active, not recruiting : Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
: Ascites
: 2010-08-24
: Behavioral: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire
Completed : Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter.
: Malignant Ascites
: 2016-03-20
:
  • Device: Ascites drainage with vascular catheter.

Completed : Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
: Malignant Ascites
: 2006-05-15
: Drug: catumaxomab Catumaxomab is administered intraperitoneally via an indwelling catheter (or port) as
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.